Publisher
Springer Berlin Heidelberg
Reference54 articles.
1. Arseneault, L., Cannon, M., Poulton, R., et al. (2002). Cannabis use in adolescence and risk for adult psychosis: Longitudinal prospective study. British Medical Journal, 325, 1212–1213.
2. Batra, A., & Bilke-Hentsch, O. (2016). Praxisbuch Sucht. Therapie der Suchterkrankungen im Jugend- und Erwachsenenalter. Stuttgart: Thieme.
3. Berardi, A., Schelling, G., & Campolongo, P. (2016). The endocannabinoid system and post traumatic stress disorder (PTSD): From preclinical findings to innovative therapeutic approaches in clinical settings. Pharmacological Research, 111, 668–678.
4. Batalla, A., Janssen, H., Gangadin, S. S., & Bossong, M. G. (2019). The potential of cannabidiol as a treatment for psychosis and addiction: Who benefits most? A systematic review. Journal of Clinical Medicine, 8(7), 1058.
5. Castaneto, M. S., Gorelick, D. A., Desrosiers, N. A., Hartman, R. L., Pirard, S., & Huestis, M. A. (2014). Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications. Drug and Alcohol Dependence, 144, 12–41.